Fosun Pharma stock reports 19.09 percent profit growth
Published on 09/24/2026 at 03:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Fosun Pharma stock stood at CNY 23.13 on the Shanghai Stock Exchange on September 23, 2026, with a market capitalization of CNY 61,049,475,976. The price was 24.8 percent below the 52-week high of CNY 30.75, while the latest interim figures show faster profit growth than revenue growth.
Profit growth outpaces revenue
According to Fosun Pharma, revenue reached RMB 20.442 billion in the first half of 2026, an increase of 4.75 percent from the same period in 2025. At constant exchange rates, revenue growth was 7.17 percent.
Adjusted profit attributable to shareholders rose 19.09 percent to RMB 1.144 billion in 1H2026, according to PR Newswire. The gap between revenue and profit growth points to improving earnings quality rather than simple top-line expansion.
Innovation drives the mix
Innovative drug revenue increased 13.84 percent year over year to RMB 4.911 billion during 1H2026, accounting for 33.21 percent of pharmaceutical segment revenue. That mix shift gives Fosun Pharma a stronger growth contribution from products with higher innovation content.
International business also expanded. Revenue from regions outside mainland China reached RMB 6.379 billion in 1H2026, up 16.45 percent year over year and representing 31.21 percent of total revenue, according to Fosun Pharma.
Cash flow adds support
Net cash generated from operating activities reached RMB 2.424 billion in 1H2026, an increase of 13.59 percent from the prior-year period. The combination of 19.09 percent adjusted profit growth and 13.59 percent operating cash flow growth is the key financial contrast for investors.
Stock remains below yearly high
Fosun Pharma stock was priced at CNY 23.13 on the Shanghai Stock Exchange on September 23, 2026. Its 52-week range was CNY 20.85 to CNY 30.75, placing the share price above the yearly low and 24.8 percent below the yearly high.
Fosun Pharma key facts
- Company: Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Ticker: 600196
- Trading venue: Shanghai Stock Exchange
- Closing price (September 23, 2026): CNY 23.13
- Market capitalization: CNY 61,049,475,976 (as of September 23, 2026)
- 52-week range: CNY 20.85-30.75 (as of September 23, 2026)
- Sector / Industry: Health Technology / Pharmaceuticals
